 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Biotest Aktiengesellschaft stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy ETR:BIO! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Biotest Aktiengesellschaft stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in haematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company’s products also comprise Cytotect for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in newborns; Hepatect for prophylaxis of hepatitis B re-infection; Intratect for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; IgG Next Genration for primary immune deficiency and immunothrombocytopenia; Varitect for the treatment of varicella zoster virus infections; Zutectra for hepatitis B re-infection prophylaxis after liver transplantation; and Cytotect 70(BT-094) for prevention of cytomegalovirus infection in the foetus during pregnancy with mother’s CMV infection. In addition, it provides Albiomin for the treatment of blood volume depletion; Biseko to treat volume and serum protein depletion; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital and acquired fibrinogen deficiency; Trimodulin for the community-acquired pneumonia; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. Biotest Aktiengesellschaft was founded in 1946 and is headquartered in Dreieich, Germany. Biotest Aktiengesellschaft is a subsidiary of Tiancheng International Investment Limited.
Average volume
1,927 shs
MARKET CAP
$569.83 million
Stock exchange
ETR
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
ETR:BIO
|
Biotechnology
|
Medical
|
3,160 shs
|
Below is a quick guide on how to buy ETR:BIO stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Biotest Aktiengesellschaft shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Biotest Aktiengesellschaft – Search for “”ETR:BIO”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Biotest Aktiengesellschaft stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Wall Street analysts have given Biotest Aktiengesellschaft (BIO.F) a “N/A” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Biotest Aktiengesellschaft (BIO.F) wasn’t one of them. Reportlab thinks these five stocks may be even better buys.
Biotest Aktiengesellschaft (BIO.F)’s stock was trading at €18.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIO shares have increased by 56.5% and is now trading at €28.80.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing ETR:BIO stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Biotest Aktiengesellschaft stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Biotest Aktiengesellschaft stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “ETR:BIO stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some ETR:BIO stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, ETR:BIO is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Biotest Aktiengesellschaft stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Biotest Aktiengesellschaft (BIO.F) pays an annual dividend of €0.04 per share and currently has a dividend yield of 0.19%.
View Biotest Aktiengesellschaft (BIO.F)’s dividend history.
Biotest Aktiengesellschaft (BIO.F)’s management team includes the following people:
Dr. Michael Ramroth, Chairman of the Management Board, CEO & CFO (Age 60, Pay $1.11M)
Dr. Georg FloÃ, COO & Member of the Board of Management
Dr. Monika Buttkereit, Head of Investor Relations
Dr. Christina Erb, Head of Corp. HR
Dr. Katrin Bernöster, Head of the Project Management Organisation
Mr. Peter Seith, Head of Quality Operations
Dr. Jörg Schüttrumpf, Head of R&D
Dr. Wolfgang M̦ller, Head of Devel. РPlasma Protein
Dr. Hermann Keuper, Sr. VP of Manufacturing
Some companies that are related to Biotest Aktiengesellschaft (BIO.F) include Trillium Therapeutics Inc. (TRIL.TO) (TRIL), BioAtla (BCAB), iTeos Therapeutics (ITOS), 4D Molecular Therapeutics (FDMT), Concordia International Corp. (CXR.TO) (CXR), PureTech Health (PRTC), Oxford Biomedica plc (OXB.L) (OXB), Inventiva (IVA), Ergomed (ERGO), Novacyt S.A. (NCYT.L) (NCYT), Burcon NutraScience Co. (BU.TO) (BU), Aptose Biosciences (APS), Silence Therapeutics plc (SLN.L) (SLN), Pfenex (PFNX) and 22nd Century Group (XXII).
View all of BIO’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Biotest Aktiengesellschaft (BIO.F) investors own include Grifols (GRFS), CSL Limited (CSL.AX) (CSL), BioXcel Therapeutics (BTAI) and ADMA Biologics (ADMA).
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying ETR:BIO stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Biotest Aktiengesellschaft (BIO.F) trades on the ETR under the ticker symbol “BIO.”
One share of BIO stock can currently be purchased for approximately €28.80.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Biotest Aktiengesellschaft (BIO.F) has a market capitalization of $569.83 million and generates $465.80 million in revenue each year.
Biotest Aktiengesellschaft (BIO.F) employs 1,837 workers across the globe.
The official website for Biotest Aktiengesellschaft (BIO.F) is www.biotest.com.
Biotest Aktiengesellschaft (BIO.F) is headquartered at Landsteinerstr. 5, DREIEICH, 63303, Germany.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Biotest Aktiengesellschaft (BIO.F)’s mailing address is Landsteinerstr. 5, DREIEICH, 63303, Germany. The company can be reached via phone at +49-6103-8010.
Company figures are crucial for assessing the state of a company, they show the financial health of a company. Below you will find an overview of this stocks figures for the past 4 years. Discover total sales, net income, gross profit, operating expenses, Research & Development expenses and more figures to get a good picture of the company with the most relevant stock history.
Reportlab does not offer advice on specific stocks. We recommend looking closely at the company, the {crypname2[1]} stock quarterly earnings, the earnings reports, the annual reports, the confidence in the company, the target market, the team, the market the company is in and other important macro economic developments to make a good choice. It is important to consider what role the company can play in the future. Finally, we always recommend keeping an eye on the latest {crypname1[1]} stock news to see if there are any major changes that will have an impact.
To sum it up, if you’re asking yourself if now is a good time to buy this stock, advisors say the answer is simple, no matter what’s happening in the markets: Yes, as long as you’re planning to invest for the long-term, are starting with small amounts invested through dollar-cost averaging and you’re investing safely.
At reportlab we want to help you with a detailed stock analysis, we want to remind you that the data provided on this website is not necessarily entirely current or accurate. The data and quotes on the website are not always provided by a market or exchange, but may also come from market makers. Therefore, the quotes may not be accurate and may differ from the actual price on a market. They are indicative quotes and are not suitable for trading purposes.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Biotest Aktiengesellschaft stock?
The safest and easiest way to buy ETR:BIO stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Biotest Aktiengesellschaft stock?
You will first want to find a licensed broker that supports ETR:BIO stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading ETR:BIO stocks in a safe and complete environment.
Is ETR:BIO stock a good investment?
As with any other asset, there is an element of risk associated with buying ETR:BIO stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Biotest Aktiengesellschaft stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with ETR:BIO is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Biotest Aktiengesellschaft stock.
How do you trade Biotest Aktiengesellschaft stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Biotest Aktiengesellschaft stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on ETR:BIO stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Biotest Aktiengesellschaft stock?
To sell your ETR:BIO stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Biotest Aktiengesellschaft stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading ETR:BIO stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
